is retatrutide approved in other countries October 27, 2025: U.K. regulators bust illicit site making unlicensed and tirzepatide pens – Partnership for Safe Medicines Beyond the GLP-1RA weight loss

Currently it's not FDA approved

CVS/MedImpact, regional Blues PBMs) have analogous policies: standard BMI thresholds, diet/exercise verification, and often a requirement to try older weight-loss drugs (like phentermine or orlistat) before GLP-1 coverage

"Effects of once-weekly subcutaneous retatrutide on weight and metabolic markers: A systematic review and meta-analysis of randomized controlled trials." Metabolism open 24 (2024): 100321

About Ozempic Ozempic (semaglutide) injection 0.5 mg or 1 mg is a once-weekly glucagon-like peptide-1 (GLP-1) receptor agonist indicated along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus and to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes mellitus with known heart disease